Drawing for RESURE

USPTO serial 75923626

RESURE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
CARLYLE, SHAUNIA P
Law office
DIVISIONAL UNIT

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with RESURE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Roberta Jacobs-Meadway

CYNTHIA B SUMMERFIELD PFIZER INC100 RT 206 NPEAPACK, NJ 07977UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005pharmaceutical preparations for the reduction of menstrual bleedingsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jan 31, 2005MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 31, 2005ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 19, 2004CFITCASE FILE IN TICRS—
Mar 11, 2004EX5GSOU EXTENSION 5 GRANTED—
Mar 2, 2004EXT5SOU EXTENSION 5 FILED—
Mar 2, 2004EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 23, 2003EX4GSOU EXTENSION 4 GRANTED—
Sep 18, 2003EXT4SOU EXTENSION 4 FILED—
Sep 18, 2003EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 18, 2003TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 13, 2003EX3GSOU EXTENSION 3 GRANTED—
Mar 3, 2003EXT3SOU EXTENSION 3 FILED—
Mar 3, 2003MAILPAPER RECEIVED—
Dec 27, 2002EX2GSOU EXTENSION 2 GRANTED—
Oct 11, 2002MAILPAPER RECEIVED—
Oct 10, 2002EXT2SOU EXTENSION 2 FILED—
Dec 17, 2001EX1GSOU EXTENSION 1 GRANTED—
Nov 28, 2001EXT1SOU EXTENSION 1 FILED—
Oct 16, 2001NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 24, 2001PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 11, 2001NPUBNOTICE OF PUBLICATION—
May 2, 2001CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 9, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 9, 2000CNSLLETTER OF SUSPENSION MAILED—
Jul 26, 2000DOCKASSIGNED TO EXAMINER—
Jul 25, 2000DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance